Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Revenue Breakdown
Breakdown by Geography
Adaptimmune Therapeutics PLC
Breakdown by Segments
Adaptimmune Therapeutics PLC
Total Revenue:
60.3m
USD
|
Refers To Development Revenue:
60.3m
USD
|